Premium Reports
Contact KLAS

Preferences

   Bookmark

Related Series

 No Related Series

 End chart zoom
SmarterDx SmarterPrebill ROI Validations 2026 SmarterDx SmarterPrebill ROI Validations 2026
* A page refresh may be necessary to see the updated image
Upcoming

SmarterDx SmarterPrebill ROI Validations 2026
Improving Documentation Completeness, Quality & Revenue

author - Tyson Blauer
Author
Tyson Blauer
author - Sidnee Wood
Author
Sidnee Wood
 
February 2026

Franciscan Missionaries of Our Lady Health (FMOL Health) identified limitations in their ability to consistently review patient records with their existing CDI resources. To address these limitations, the organization implemented SmarterDx’s SmarterPrebill—an AI-driven clinical documentation integrity and coding review solution—to expand documentation coverage and better support quality reporting and revenue integrity. After coding but before billing, the solution analyzes coded inpatient encounters and surfaces potential documentation and coding opportunities for human review. Since implementing this solution, FMOL Health has expanded documentation coverage and improved capture of patient illness severity, leading to an estimated $30 million increase in net revenue as well as early improvement with quality metrics.

to see the full dataset.

If you don't have a login, getting started is easy.

Provider Organizations
Fill out our registration form to verify your organization.
HIT Companies
Contact a KLAS representative for plans and pricing.
author - Natalie Hopkins
Writer
Natalie Hopkins
author - Kath Spencer
Designer
Kath Spencer
author - Kyle Chilton
Project Manager
Kyle Chilton

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2026 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.

​